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Original Research
Platelet-Rich Plasma Injection
With Percutaneous Needling for
Recalcitrant Lateral Epicondylitis
Comparison of Tenotomy and Fenestration Techniques
Michael P. Gaspar,*†‡ MD, Michael A. Motto,§ BS, Sarah Lewis,†|| MD, DPT,
Sidney M. Jacoby,† MD, Randall W. Culp,† MD, A. Lee Osterman,† MD, and Patrick M. Kane,† MD
Investigation performed at the Philadelphia Hand to Shoulder Center, Department of Orthopaedic
Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Background: Recalcitrant lateral epicondylitis (LE) is a common debilitating condition, with numerous treatment options of varying
success. An injection of platelet-rich plasma (PRP) has been shown to improve LE, although it is unclear whether the method of
needling used in conjunction with a PRP injection is of clinical importance.
Purpose: To determine whether percutaneous needle tenotomy is superior to percutaneous needle fenestration when each is
combined with a PRP injection for the treatment of recalcitrant LE.
Study Design: Cohort study; Level of evidence, 3.
Methods: A total of 93 patients with recalcitrant LE were treated with a PRP injection and percutaneous needle fenestration
(n ¼ 45) or percutaneous needle tenotomy (n ¼ 48) over a 5-year study interval. Preoperative patient data, including visual analog
scale for pain (VAS-P), Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH), and Patient-Rated Tennis Elbow Evaluation
(PRTEE) scores and grip strength, were obtained from a chart review and compared with postoperative values obtained pro-
spectively. Secondary outcomes included the incidence of complications, need for additional interventions, return to work, and
patient satisfaction.
Results: At a mean follow-up of 40 months, significant improvements in VAS-P (mean, –6.1; 95% CI, –6.8 to –5.5; P < .0001),
QuickDASH (mean, –46; 95% CI, –52 to –40; P < .0001), and PRTEE (mean, –57; 95% CI, –64 to –50; P < .0001) scores and grip
strength (mean, þ6.1 kg; 95% CI, 4.9 to 7.3; P < .0001) were observed across the entire study cohort, with no significant differ-
ences noted between the fenestration and tenotomy groups. Nine of 45 patients (22%) underwent additional procedures to treat
recurrent symptoms in the fenestration group compared with 5 of 48 patients (10%) in the tenotomy group (P ¼ .05). No com-
plications occurred in any patients, and no patients expressed dissatisfaction with their treatment course.
Conclusion: A PRP injection with concomitant percutaneous needling is an effective treatment for recalcitrant LE, with sustained
improvements in pain, strength, and function demonstrated at a mean follow-up of longer than 3 years. Although the method of
concomitant needling does not appear to have a significant effect on treatment outcomes, more aggressive needle tenotomy is
less likely to require conversion to open tenotomy than needle fenestration in the short term to midterm.
Keywords: lateral epicondylitis; percutaneous needle tenotomy; platelet-rich plasma (PRP); tendinosis; tennis elbow; fenestration
Lateral epicondylitis (LE) is a commonly occurring condi-
tion that affects up to 3% of the adult population while
accounting for significant costs related to medical care and
lost wages.14,30,43,53 Often referred to as tennis elbow, the
underlying cause of LE involves noninflammatory pro-
cesses of mucoid degeneration with neovascularization,
scarring, and microtearing at the extensor origin at the
lateral elbow, collectively termed angiofibroblastic hyper-
plasia or tendinosis.1,39 As LE is considered to be self-
limiting in the majority of patients, first-line treatment
options generally focus on addressing the primary
symptom of pain and may include oral and/or topical anti-
inflammatory drugs and analgesics, bracing, stretching,
and other physical therapy measures.6,30,40,45 Although for
most patients, pain resolves within 1 year of onset with
nonoperative treatment alone, a smaller but significant
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population will continue to have persistent symptoms that
are refractory to noninvasive treatment and will be deemed
to have recalcitrant LE.26
Patients with recalcitrant LE are particularly difficult to
treat, as outcomes are generally suboptimal, while the most
favorable treatment regimens continue to be debated. The
least invasive options involve injections of corticosteroids,
platelet-rich plasma (PRP), or other autologous derivatives,
such as whole blood and tenocyte concentrate.2,37,41,51,54
However, these treatments are not without complications
of their own; this is particularly true for corticosteroids,
which carry the risks of tendon atrophy and blood glucose
spikes.8,13,49 Furthermore, while most evidence suggests
that PRP is superior to corticosteroids in the long term, the
superiority of one over the other has still not reached
consensus.2,11,12,22,27,28,37,45 This is important, given the
fact that corticosteroid and PRP injections are thought to
act in opposing pathways, as corticosteroids are known
inhibitors of inflammation, while animal models suggest
that PRP induces a transient inflammatory response to
stimulate a repair response.23
Surgical treatment for recalcitrant LE, pioneered by
Nirschl, included lateral release with debridement of the
common extensor origin and has been shown to result in
sustainable relief for over 1 decade.10,16,17,39 Nirschl and
Pettrone39 suggested that the success of this procedure was
secondary to the removal of diseased tissue, combined with
bony decortication stimulating local blood flow. Since then,
this concept has been modified to include arthroscopic and
less invasive techniques, although the underlying method
of tendon release or debridement has persisted.3,16,29,47,50
Percutaneous tenotomy is favored by some, as it is reported
to yield a lower severity and incidence of complications
compared with open techniques.4,31-36,38,42,44,52
While positive outcomes after either a PRP injection or per-
cutaneous needle tenotomy alone have been reported for the
treatment of recalcitrant LE, to our knowledge, results after
the two performed in conjunctionhavenot been reported. Fur-
thermore, it is not known if a PRP injection combined with
moreaggressivepercutaneousneedle tenotomyprovidessupe-
rior symptom relief than a PRP injection performed with a
needle fenestration technique. Given the potential additive
effects of PRP stimulating a repair response and decortication
promoting increased blood flow, we hypothesized that a PRP
injection performed in conjunction with needle tenotomy
would result in superior outcomes compared with a PRP
injection with needle fenestration. The purpose of this
study was to determine if outcomes differed between
patients with LE treated with a PRP injection plus per-
cutaneous needle tenotomy and those treated with a PRP
injection and percutaneous needle fenestration.
METHODS
This study was approved by our institutional review board.
We queried our departmental electronic database to identify
patientswhoreceivedaPRPinjectionwithpercutaneousnee-
dling for LE from January 2010 throughDecember 2014 by 1
of 2 senior, fellowship-trained orthopaedic hand and upper
extremity surgeons. Per their personal preferences, one sur-
geon (R.W.C.) performedneedlingwith the fenestration tech-
nique, while the other (A.L.O.) performed needle tenotomy.
Both surgeons utilized the following patient selection crite-
ria:minimumsymptomduration of 6months, physical exam-
ination and magnetic resonance imaging (MRI) findings
consistent with LE, and failed nonoperative management
including all of the following: at least 1 prior corticosteroid
injection, supervised therapy, and trial of splinting and/or
counterforce bracing. Patients were excluded if they met any
of the following criteria: open lateral epicondyle tenotomy,
prior surgery or PRP injection for LE of the same elbow, cor-
ticosteroid injection within 3 months before the PRP injec-
tion, history of inflammatory arthropathy, or history of
significant trauma about the elbow. For patients with bilat-
eral LE treated with a PRP injection, only the first injection
was included in the analysis.
Procedure and Postoperative Rehabilitation
All procedures were performed under sterile conditions in
the operating room. Approximately 30 mL of venous blood
was drawn from each patient and processed using the ACP
Double Syringe System (Arthrex Inc) to obtain PRP for an
injection. Anesthesia was typically administered either via
axillary nerve blockade or local anesthesia with sedation.
For both techniques, after the surface anatomy was
mapped with a surgical pen, an 18-gauge needle was intro-
duced through the skin overlying the common extensor ten-
don. The procedure in the fenestration group was
performed in a similar fashion to previously reported stud-
ies (often referred to as “peppering”), whereby the needle
was used to perforate the common extensor origin 5 times
through the single skin entry site.22,28,37,41 For the teno-
tomy group, after needle entry through the skin, the beveled
edge of the needle tip was used to abrade the footprint of the
common extensor tendon until a change in feedback was
felt by the surgeon, after which PRP was then injected at
the site. The change in feedback indicated a softening of
tendinotic, diseased tendon with smoothening of bony
irregularities.33,34 After both techniques, the elbow was
then ranged to rule out iatrogenic injuries to the lateral
stabilizers, and a sterile dressing was placed on the elbow.
Postoperatively, the patient was permitted to use the arm
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as tolerated. Rehabilitation protocols were identical between
the groups and included range of motion exercises starting
at 1 week and strengthening at 3 weeks.
Data Collection and Statistical Analysis
A retrospective chart review was performed to obtain
patient demographic and disease-specific factors, including
age, sex, handedness, medical comorbidities, work status,
workers’ compensation status, duration of symptoms, and
prior treatment. Examination findings included preopera-
tive grip strength, tenderness over the common extensor
origin (yes or no), and pain with resisted wrist extension
(yes or no). Per our institution’s standard, documented grip
strength was determined by the mean of 3 trials with the
Jamar hand dynamometer (Sammons Preston Inc) on set-
tings II and III for female and male patients, respectively.
Preoperative visual analog scale for pain (VAS-P; 0 ¼ no
pain, 10 ¼ worst pain imaginable) scores and Quick Dis-
abilities of the Arm, Shoulder and Hand (QuickDASH) and
Patient-Rated Tennis Elbow Evaluation (PRTEE) func-
tional scores were also recorded. Patients were invited back
to our center for a follow-up evaluation, which was per-
formed by a study team member (M.P.G.) blinded to the
original procedure. The follow-up evaluation included
interval history taking; a repeat clinical examination; and
postoperative VAS-P, QuickDASH, and PRTEE scores.
Follow-up assessments of point tenderness and pain with
resisted wrist extension were compared with preoperative
findings using a custom Likert-type scale scored from 1 to
5 tomaintain consistencywith the format of theQuickDASH;
in addition, patient satisfaction was assessed using a similar
custom Likert-type scale (Table 1). Secondary data and qual-
itative outcomes thatwere recorded included patients’ preop-
erative and postoperative work status, incidence of
complications, and need for additional interventions.
Univariate analysis was utilized to obtain descriptive
statistics of the entire cohort, and bivariate analysis was
performed with the Fisher exact and independent t tests to
compare baseline preoperative patient demographics
between the tenotomy and fenestration groups. Preoperative
and postoperative values within each treatment group were
compared using paired t testing, while improvements
between the 2 groups were compared using independent t
testing. All statistical analyses were performed using Mini-
tab for Windows (version 17.3.1; Minitab Inc). An a priori
power analysis was performed using the QuickDASH in a
manner analogous to the use of the PRTEE reported by
Krogh and colleagues.28 We elected to use the QuickDASH
for power analysis, given the previously established mini-
mal clinically important difference (MCID) for the Quick-
DASH of 14 ± 14 reported by Sorensen et al48 and a more
recent similar MCID of 15.8 reported that specifically per-
tained to LE.46 Thus, for a 2-sided significance level a ¼ .05
to achieve 80% power (b¼ .8), a sample size of 17 patients in
each group would be necessary to detect an effect size of 1.0.
RESULTS
Ninety-three patients (50 female, 43 male) satisfied the
inclusion criteria for this study. The mean age across the
entire cohort was 51.7 ± 8.1 years. The mean interval from
the onset of symptoms to the PRP injection was 26.8 ± 23.6
months (range, 6.2-127.8 months), while the mean follow-up
interval was 39.7 ± 19.3 months (range, 12.2-80.8 months).
All patients had preoperative MRI findings consistent with
LE, tenderness to palpation over the common extensor ori-
gin, and pain with resisted wrist extension. Additionally, all
patients had failed a trial of conservative management
including physical therapy (including stretching, splinting,
and/or bracing) and corticosteroid injection(s); the mean
number of corticosteroid injections before the PRP injection
was 1.54 ± 0.83. Overall, 45 and 48 patients comprised the
fenestration and tenotomy groups, respectively. There was
no difference in the baseline demographics between the
study groups, as outlined in Table 2.
Outcomes
Postoperatively, mean grip strength (þ6.1 kg; 95% CI, 4.9 to
7.3; P < .0001) and mean VAS-P (–6.1; 95% CI, –6.8 to –5.5;
TABLE 1
Custom Likert Scale to Assess Changes in Clinical Examination Findings and Final Patient Satisfaction With Treatmenta
Outcome:
Question
Point Tenderness:
How Tender Are You at This Site
Compared With Preoperatively?
Pain With Resisted Wrist Extension:
How Is Your Pain With This Maneuver
Compared With Preoperatively?
Satisfaction:
At This Time, How Satisfied Are You With
the End Results of Your Treatment?
1 Minimal to no tenderness;
significantly improved
Minimal to no pain; significantly improved Highest possible satisfaction; would
definitely undergo this surgery again
2 Some mild tenderness; somewhat
improved
Mild pain; somewhat improved Satisfied; would likely undergo this
surgery again
3 Tenderness is present; unchanged Pain is unchanged Neither satisfied nor dissatisfied; unsure if
would undergo surgery again
4 Moderate but not severe
tenderness; worsened
Moderate but not severe pain does not limit
ability to fully extend wrist; worsened
Dissatisfied; unlikely to undergo this
surgery again
5 Severe tenderness; significantly
worsened
Extreme pain causing weakness or inability to
fully extend wrist; significantly worsened
Lowest possible satisfaction; would
definitely not undergo this surgery again
aPatients were asked to select the answer that best fit their self-assessment.
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P < .0001), QuickDASH (–46; 95% CI, –52 to –40; P < .0001),
and PRTEE (–57; 95% CI, –64 to –50; P < .0001) scores were
significantly improved across the entire study cohort com-
pared with preoperative values. Mean postoperative pain
with resisted wrist extension and tenderness values across
the cohort were 1.98 ± 0.84 and 1.75 ± 0.71, respectively.
A comparison of outcomes between the fenestration and
tenotomy groups is depicted in Table 3.
When comparing the final postoperative VAS-P score
between the groups, the tenotomy group had a significantly
lower VAS-P score than the fenestration group (Table 4),
although the absolute preoperative versus postoperative
difference was not significant (Table 3). Similarly, while the
difference in final postoperative grip strength approached
statistical significance (higher for the fenestration group),
the preoperative versus postoperative difference between
the groups was again nonsignificant. No other significant
differences were found between the fenestration and
tenotomy groups for any of the aforementioned variables
(Tables 3 and 4).
Excluding those patients who were retired or already
working full-time at the point of their initial procedure,
33 of 49 (67%) patients with preoperative work restrictions,
that is, those either out of work or working a modified time/
light duty, increased their work capacity by final follow-up.
All 16 of those patients whose work capacity did not
improve were workers’ compensation patients. No patients
in either group were working in a lesser capacity than pre-
operatively. The mean satisfaction score across the full
study cohort was 1.22 ± 0.51, with no patients scoring worse
than 3.
Additional Procedures
Of the 93 patients, 14 (15%) underwent a second procedure.
Three patients in each group received a second PRP injec-
tion for recurrent symptoms; 5 of those patients subse-
quently did well and required no further interventions.
One patient who received a second PRP injection in the
fenestration group had minimal symptom relief after the
second injection and was subsequently converted to open
tenotomy. Six additional patients in the fenestration group
were converted to open tenotomy versus 2 patients in the
tenotomy group (P ¼ .05). The mean interval from the ini-
tial PRP injection to the second procedure was 9.7 ± 7.6
months (range, 2.6-30.1 months). No complications
occurred in any patients.
DISCUSSION
Despite a wealth of treatments available for patients with
recalcitrant LE, an effective consensus or gold-standard
option remains elusive. Nirschl and Pettrone39 first
reported histopathological findings confirming the condi-
tion to be a degenerative process rather than one of an
inflammatory cause. In their series of 88 elbows treated
with open debridement and repair at the common extensor
origin, over 97% demonstrated improvement compared
with preoperative symptoms.39 Less invasive variations of
the now-eponymous Nirschl procedure have since been
described to include arthroscopic or percutaneous tenotomy
and debridement of the common extensor origin, while
repair of the tendon is no longer considered to be critical.||
Needle tenotomy in particular has been shown to yield pos-
itive outcomes, although comparative data relative to other
options are lacking.32-34,55 Furthermore, we found that
there was a substantial variability between studies as to
the true definition of tenotomy, ranging from needle
TABLE 3
Comparison of Treatment Outcomes Between the Groupsa
Variable
Fenestration
(n ¼ 45)
Tenotomy
(n ¼ 48)
P
Value
Grip strength improvement,
kg
7.1 ± 5.4 5.2 ± 4.7 .12
VAS-P score improvement 5.8 ± 2.4 6.5 ± 2.4 .28
QuickDASH score
improvement
47.5 ± 21.5 44.2 ± 22.0 .56
PRTEE score improvement 52.0 ± 24.1 61.6 ± 25.2 .18
Second procedure 10 (22) 5 (10) .16
PRP re-injection 3 (30) 3 (60) >.99
Open tenotomy 7 (70) 2 (40) .05
Improved work status 17/24 (71) 16/25 (64) .61
Modified duty to full-time 15/16 (94) 9/11 (82)
Out of work to modified duty 2/8 (25) 7/14 (50)
Patient satisfaction 1.27 ± 0.58 1.17 ± 0.43 .35
Postoperative tenderness 1.71 ± 0.71 1.79 ± 0.73 .59
Postoperative pain with
resisted wrist extension
2.02 ± 0.81 1.94 ± 0.86 .63
aValues are shown as mean ± SD or n (%). PRP, platelet-rich
plasma; PRTEE, Patient-Rated Tennis Elbow Evaluation; Quick-
DASH, Quick Disabilities of the Arm, Shoulder and Hand; VAS-P,
visual analog scale for pain.
TABLE 2
Comparison of Baseline Demographic Data
Between the Groupsa
Variable
Fenestration
(n ¼ 45)
Tenotomy
(n ¼ 48)
P
Value
Age, y 50.3 ± 8.1 52.9 ± 8.0 .13
Interval from symptom onset to
injection, mo
24.7 ± 20.9 28.5 ± 26.1 .48
Follow-up duration, mo 39.4 ± 21.6 40.0 ± 17.2 .87
Female sex 23 (51) 27 (56) .68
Dominant side 29 (64) 27 (56) .55
Work status .75
Full-time 18 (40) 18 (38)
Modified duty 16 (36) 11 (23)
Out of work 8 (18) 14 (29)
Retired 3 (6) 5 (10)
Workers’ compensation 15 (33) 19 (40) .53
Diabetes 12 (27) 11 (23) .81
No. of prior steroid injections 1.53 ± 0.82 1.54 ± 0.85 .96
aValues are shown as mean ± SD or n (%).
||References 4, 16, 29, 31, 38, 42, 44, 47, 50, 52.
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fenestration of the diseased tendon to debridement of the
underlying bone.18,32-34,55 McShane and colleagues33
reported on a prospective series of 58 patients treated with
needle tenotomy under ultrasound guidance, which they
described as “repeatedly fenestrat[ing] the tendinotic
tendon,” followed by abrading the periosteum of the lateral
epicondyle with the beveled needle edge, and finally, inject-
ing a corticosteroid. In that report, 80% of patients reported
excellent or good outcomes, although no objective measures
or validated outcome instruments were used.33 In a follow-
up study by the same authors, 57 patients were treated in
an identical fashion but without a corticosteroid injection,
resulting in over 92% of patients with good or excellent
outcomes.34 In a similar study, Zhu et al55 reported on 76
patients treated with ultrasound-guided needle “puncture”
(without periosteal abrading), yielding 87% good or excel-
lent outcomes. None of the 3 aforementioned studies
included a comparison group or validated outcome
measures.
As interest in more cost-efficient, nonsurgical methods
has increased, definitive treatment with injectable thera-
pies has also garnered more attention.{ PRP in particular
has gained increasing popularity as an autologous thera-
peutic agent targeting a range of tendinopathies, including
LE.18,19 The exact mechanism by which PRP improves the
symptoms of tendinopathy is still not entirely understood,
although recent genomic work suggests that PRP incites a
transient but substantial inflammatory process in fibro-
blasts within the diseased tendon, subsequently inducing
signaling pathways involved in tendon regeneration.23 This
is supported by clinical reports demonstrating the positive
effects of PRP to generally outlast those of corticosteroid
injections.2,22,28,41
Based on the potential individual benefits of tenotomy
and PRP injections, we hypothesized that a PRP injection
and percutaneous needle tenotomy would have an additive
effect on outcomes, with superior results in patients with
recalcitrant LE as compared with a PRP injection with the
needle fenestration technique. We found that outcomes
were largely similar between the groups, with the exception
of final pain scores and grip strength. However, this differ-
ence was not observed when comparing themean difference
between the groups from preoperatively to postoperatively.
Despite a potentially synergistic effect against recalcitrant
LE, we found that needle tenotomy offered no significant
additional benefit to needle fenestration regarding out-
comes when both were combined with a PRP injection.
We suspect that this is more reflective of a largely positive
effect of the PRP injection rather than a marginal effect
from tenotomy. From a pathophysiological standpoint, this
may be explained by a large inflammatory effect of PRP, as
described by Hudgens et al,23 surpassing the combined
mechanical effect of tenotomy on the degenerative tendon
and its own mild incitation of inflammatory processes.
In addition to differences in symptomatic and functional
outcomes, a key question that we aimed to answer was the
relative complication and failure rates and the need for
additional interventions. We found that the need for revi-
sion open tenotomy was significantly higher in the fenes-
tration group than in the tenotomy group. One possible
explanation for this difference is that the tenotomy proce-
dure involves more aggressive abrading of tendinotic tissue
than fenestration, with the latter process not adequately
stimulate a repair response in the diseased tissue, thus
allowing for symptoms to recur. Despite this difference, the
overall revision rate of 15% across all patients lends further
credence to the argument that a single PRP injection may
serve as an alternative to surgery for the definitive treat-
ment of recalcitrant LE.20,21,24
This study is not without limitations, most notably the
retrospective nature of preoperative data collection. This
was especially likely to introduce bias with subjective
assessments such as pain with resisted wrist extension or
point tenderness. Although it would have been ideal to use
the VAS-P or a Likert-type scale for these preoperative
values, the lack of such details from clinical documentation
precluded us from doing so. Thus, we elected to use the
binary yes/no format and rely on our postoperative scales,
which are of course subject to their own inherent recall
bias. Another limitation is regarding the surgical technique
itself. We did not use ultrasound for guidance to localize
needle placement or for the evaluation of tendon quality
postoperatively. This should be noted in light of recent find-
ings by Keijsers et al,25 who reported that the majority of
injections were intra-articular rather than intratendinous.
However, with the combined experience of the 2 senior
authors (R.W.C., A.L.O.) who performed the procedure at
more than 60 years in practice, we feel that this risk was
likely minimal. Another noteworthy limitation was the
TABLE 4
Comparison of Preoperative and Postoperative Quantitative Outcomes Between the Groupsa
Outcome Measure
Preoperative Postoperative
Fenestration Tenotomy P Value Fenestration Tenotomy P Value
Grip strength, kg 24.9 ± 11.7 22.8 ± 8.8 .33 32.0 ± 12.7 28.0 ± 10.0 .09
VAS-P score 8.1 ± 1.5 7.8 ± 1.7 .46 2.3 ± 2.1 1.3 ± 1.6 .05
QuickDASH score 58.7 ± 18.9 61.6 ± 22.0 .63 11.2 ± 17.9 17.4 ± 16.4 .21
PRTEE score 72.1 ± 22.8 75.2 ± 19.6 .61 20.1 ± 17.7 13.6 ± 17.8 .20
aData are shown as mean ± SD. PRTEE, Patient-Rated Tennis Elbow Evaluation; QuickDASH, Quick Disabilities of the Arm, Shoulder
and Hand; VAS-P, visual analog scale for pain.
{References 2, 5, 7, 9, 11, 15, 21, 22, 27, 28, 37, 41, 51, 54.
The Orthopaedic Journal of Sports Medicine PRP With Needling for Tennis Elbow 5
absence of a true control group, such as a cohort treated
with tenotomy and saline.
Despite these limitations, we feel that this study further
supports the utility of PRP injections for the treatment of
recalcitrant LE, with significant improvements observed
in pain, function, and strength, for a mean duration of
longer than 3 years and, in some patients, up to 6 years.
Outcomes of a PRP injection combined with percutaneous
needle tenotomy were not significantly different than
those of a PRP injection and percutaneous needle fenes-
tration, although more aggressive abrading with needle
tenotomy resulted in a significantly lower rate of conver-
sion to open tenotomy compared with needle fenestration.
Future prospective randomized studies could further test
this finding, and the addition of needle tenotomy and nee-
dle fenestration arms without a PRP injection would be
warranted in such a study.
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